Please Wait

Applying Filters...

Find excipient solutions to address Sugammadex formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Sugammadex

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

83 API Suppliers, 29 USDMF, 9 JDMF, 13 EU WC, 25 KDMF, 26 NDC API, 49 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

45 FDF Dossiers, 15 FDA Orange Book, 3 Europe, 1 Canada, 12 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 200MG BASE/2ML (EQ 100MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Actylis

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 28 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

12 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 4 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 3 Others

$ Xls

Filters

Sugammadex

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

HYDROCHLORIC ACID NF

EASL Congress

Not Confirmed